Market closedADR

Nanobiotix/$NBTX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Nanobiotix

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Ticker

$NBTX
Trading on

Industry

Biotechnology
Headquarters

Employees

110

Nanobiotix Metrics

BasicAdvanced
$161M
Market cap
-
P/E ratio
-$0.82
EPS
1.29
Beta
-
Dividend rate
$161M
1.29
$8.96
$2.76
36K
1.424
1.364
-202.819
-225.779
-2.79%
-22.02%
88.60%
3.228
-7.02
-7.02
-88.418
526.17%
-53.64%
167.86%
-18.34%

What the Analysts think about Nanobiotix

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Nanobiotix stock.

Nanobiotix Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Nanobiotix Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NBTX

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Nanobiotix stock?

Nanobiotix (NBTX) has a market cap of $161M as of December 15, 2024.

What is the P/E ratio for Nanobiotix stock?

The price to earnings (P/E) ratio for Nanobiotix (NBTX) stock is 0 as of December 15, 2024.

Does Nanobiotix stock pay dividends?

No, Nanobiotix (NBTX) stock does not pay dividends to its shareholders as of December 15, 2024.

When is the next Nanobiotix dividend payment date?

Nanobiotix (NBTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Nanobiotix?

Nanobiotix (NBTX) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.